The journey through pediatric cancer treatment is a formidable one, marked not only by rigorous
The ability to precisely visualize and manipulate molecular machinery inside living cells has long
A groundbreaking study published in the journal Genes has fundamentally altered the scientific landscape for hypermobile Ehlers-Danlos syndrome (hEDS), proposing that the condition’s origins are not rooted in a single genetic flaw but rather a complex accumulation of variants across three distinct
The burgeoning market for GLP-1 weight-loss medications created a gold rush for telehealth companies, but for Hims & Hers, a bold move into this lucrative space has rapidly devolved into a multi-front battle with regulators and pharmaceutical giants. The company's recent announcement that it would
With a deep background in biopharmaceutical research and development, Ivan Kairatov has a keen eye
The emergence of cell-cultured protein has sparked intense debate at the intersection of
The biopharmaceutical sector is entering a new era. After last year's market disruptions, the industry faces a harsh truth: scientific breakthroughs alone are no longer enough to keep ahead of the…
By 2030, the tissue-engineering market is projected to exceed $32.45 billion , reflecting a
The landscape of rare disease drug development is littered with clinical failures. For every
Major policy changes are colliding with the complex economics of drug development. For B2B
Biopharma companies have always operated at the edge of uncertainty. Scientific discovery is
A transformative artificial intelligence tool promises to redefine cardiac care by enabling a standard imaging technique to see what was previously invisible: the specific arterial plaques most likely to cause a catastrophic heart attack. Researchers at the Korea Advanced Institute of Science and
Across vast stretches of rural America, the silence of isolation is often broken by a growing
A groundbreaking artificial intelligence method offers a profound new capability in cardiovascular
